High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry
| UDC.coleccion | Investigación | es_ES |
| UDC.conferenceTitle | International Liver Congress | es_ES |
| UDC.departamento | Fisioterapia, Medicina e Ciencias Biomédicas | es_ES |
| UDC.grupoInv | Enfermidades Infecciosas: Hepatite e SIDA | es_ES |
| UDC.issue | Suppplement 1 | es_ES |
| UDC.journalTitle | Journal of Hepatology | es_ES |
| UDC.startPage | S311 | es_ES |
| UDC.volume | 66 | es_ES |
| dc.contributor.author | Aranda, E.B. | |
| dc.contributor.author | Mariño, Zoe | |
| dc.contributor.author | Calvo, S. | |
| dc.contributor.author | Carrión, José A. | |
| dc.contributor.author | Fernández, I. | |
| dc.contributor.author | García-Samaniego, J. | |
| dc.contributor.author | Baliellas, Carme | |
| dc.contributor.author | Pascasio Acevedo, Juan Manuel | |
| dc.contributor.author | Albillos, A. | |
| dc.contributor.author | Carrillo, C.F. | |
| dc.contributor.author | Castro-Iglesias, Ángeles | |
| dc.contributor.author | Moreno Planas, José María | |
| dc.contributor.author | Giner, C.P. | |
| dc.contributor.author | Palomares, J.J.M. | |
| dc.contributor.author | Llaneras, J. | |
| dc.contributor.author | Arenas, Juan | |
| dc.contributor.author | Fernández-Bermejo, M. | |
| dc.contributor.author | Fernández, C. | |
| dc.contributor.author | López, R.M.G. | |
| dc.contributor.author | García, P.B. | |
| dc.contributor.author | Romero-Gómez, Manuel | |
| dc.contributor.author | Sáez-Royuela, F. | |
| dc.date.accessioned | 2019-01-30T10:05:27Z | |
| dc.date.available | 2019-01-30T10:05:27Z | |
| dc.date.issued | 2017 | |
| dc.description | Poster presentation | es_ES |
| dc.identifier.citation | Aranda EB, Mariño Z, Calvo S, et al. High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry. En: Abstract of The International Liver Congress, 52nd Annual Meeting of the European Association for the Study of the Liver; 2017 Abr 19-23; Amsterdam. Amsterdam: Elsevier; 2017. p. S311 (Journal of Hepatology. 2017; 66 Suppl 1) | es_ES |
| dc.identifier.issn | 0168-8278 | |
| dc.identifier.uri | http://hdl.handle.net/2183/21636 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.relation.uri | https://doi.org/10.1016/S0168-8278(17)30942-X | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 4.0 | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry | es_ES |
| dc.type | conference output | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | f6aa3126-5f84-436d-9da4-f62438f45c9e | |
| relation.isAuthorOfPublication.latestForDiscovery | f6aa3126-5f84-436d-9da4-f62438f45c9e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Aranda_THU275.pdf
- Size:
- 140.05 KB
- Format:
- Adobe Portable Document Format
- Description:

